Trial intelligence / Profile preview

Nebulized Bronchodilators in Mechanical Ventilation Modes

NCT03271905Unknown

Sponsor
Universidade Federal do Rio Grande do Norte
Start
Apr 2017
Primary completion
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial of salbutamol and ipratropium bromide in chronic obstructive pulmonary disease (COPD) and asthma, sponsored by Universidade Federal do Rio Grande do Norte. Status: unknown.

02

Drugs

salbutamolipratropium bromide
03

Conditions

chronic obstructive pulmonary disease (COPD)asthma

Beyond the preview

Go deeper on NCT03271905.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03271905.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call